Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Current Assets (2013 - 2026)

Updated

Theravance Biopharma (TBPH) posted Current Assets of $416.66 million for Q2 2026, up 13.8% from $366.29 million a year earlier but down 0.2% from the prior quarter.

Analysis

Theravance Biopharma (TBPH) Current Assets (2013 - 2026) Analysis & Trends

At the end of FY2025, Theravance Biopharma's Current Assets came in at $418.46 million, up 159.8% from FY2024.

  • Annual Current Assets shows a five-year compound annual growth rate of 1.2% (FY2020 to FY2025).
  • In prior years, Theravance Biopharma's Current Assets was $161.07 million in FY2024 (+20.6%), $133.54 million in FY2023 (-62.2%), $353.46 million in FY2022 (+41.5%) and $249.87 million in FY2021 (-36.5%).
  • Quarterly Current Assets has run from a low of $116.48 million in Q3 2024 to a high of $511.72 million in Q3 2022 over five years.
  • On a year-over-year basis, Current Assets has increased in each of the last seven quarters, with growth averaging 97.1% over the last eight quarters.
  • The strongest year-over-year quarter for Current Assets in the past five years was Q2 2025, with growth of 207.0%; the weakest was Q3 2023, with a decline of 68.4%.
  • According to Business Quant data, Current Assets for the three prior quarters was $417.63 million (Q1 2026), $418.46 million (Q4 2025) and $354.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn - 416.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 416.66 Mn
Mar 31, 2026 417.63 Mn
Dec 31, 2025 418.46 Mn
Sep 30, 2025 354.70 Mn
Jun 30, 2025 366.29 Mn
Mar 31, 2025 150.26 Mn
Dec 31, 2024 161.07 Mn
Sep 30, 2024 116.48 Mn
Jun 30, 2024 119.31 Mn
Mar 31, 2024 124.29 Mn
Dec 31, 2023 133.54 Mn
Sep 30, 2023 161.69 Mn
Jun 30, 2023 192.00 Mn
Mar 31, 2023 261.34 Mn
Dec 31, 2022 353.46 Mn
Sep 30, 2022 511.72 Mn
Jun 30, 2022 154.73 Mn
Mar 31, 2022 204.64 Mn
Dec 31, 2021 249.87 Mn
Sep 30, 2021 297.17 Mn
API Access

Theravance Biopharma Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=TBPH&period=max&api_key=YOUR_API_KEY